Follow

Hamlet Pharma AB

Spotlight Stock Market (Sweden)

Hamlet Pharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.

Sector:
HEALTH CARE
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
HAMLET B
SE0015661152
Spotlight Stock Market
Sweden (SE)
Details of share in Hamlet Pharma AB with ticker HAMLET B
Status
Active
Amount of instruments
100 874 697
Currency
SEK
First trading date
23 Oct 2015
Type
Price
Pre-money
Time
Files
IPO
4.50 SEK
88.59M SEK
04 Sep - 23 Sep 2015
IPO in Hamlet Pharma AB
Type
Price
Pre-money
Time
Files
Exercise
4.50 SEK
113.34M SEK
10 May - 24 May 2016
Option exercise terms for HAMLET TO1
Type
Price
Pre-money
Time
Files
Exercise
4.50 SEK
125.55M SEK
11 Oct - 25 Oct 2016
Option exercise terms for HAMLET TO2
Type
Price
Pre-money
Time
Files
Directed issue
10.35 SEK
01 Feb 2019
Share issue in Hamlet Pharma AB
Type
Price
Pre-money
Time
Files
Rights issue
6.50 SEK
655.69M SEK
06 Jul - 20 Jul 2021
Share issue in Hamlet Pharma AB
Type
Ticker
ISIN
Market
OPTION
HAMLET TO3
SE0016276638
Spotlight Stock Market
Sweden (SE)
Details of option in Hamlet Pharma AB with ticker HAMLET TO3
Status
Active
Amount of instruments
3 879 796
Currency
SEK
Trading period
10 Sep 2021 - 27 May 2022
Terms
One (1) warrant of series TO3 entitles the holder to subscribe for one (1) new B share for the price which corresponds to 75 percent of the volume weighted average trading price during the ten (10) trading days preceding May 17, 2022, however, not more than SEK 10.0 per share.
Update (03.09.2021): First trading day for warrants TO3 is September 10, 2021.
Update (06.09.2021): Information regarding Hamlet Pharma warrants.
Type
Price
Pre-money
Time
Files
Exercise
17 May - 31 May 2022
Option exercise terms for HAMLET TO3
Type
Ticker
ISIN
Market
OPTION
HAMLET TO4
SE0016276646
Spotlight Stock Market
Sweden (SE)
Details of option in Hamlet Pharma AB with ticker HAMLET TO4
Status
Active
Amount of instruments
3 879 796
Currency
SEK
Trading period
10 Sep 2021 - 29 May 2023
Terms
One (1) warrant of series TO4 entitles the holder to subscribe for one (1) new A share for the price which corresponds to 75 percent of the volume weighted average trading price during the ten (10) trading days preceding May 17, 2022, however, not more than SEK 13.0 per share.
Update (03.09.2021): First trading day for warrants TO4 is September 10, 2021.
Update (06.09.2021): Information regarding Hamlet Pharma warrants.
Type
Price
Pre-money
Time
Files
Exercise
17 May - 31 May 2023
Option exercise terms for HAMLET TO4
Type
Ticker
ISIN
Market
SHARE
HAMLET
SE0007192026
Spotlight Stock Market
Sweden (SE)
Details of share in Hamlet Pharma AB with ticker HAMLET
Status
Archived
Amount of instruments
33 624 899
Currency
SEK
First trading date
23 Oct 2015
Type
Price
Pre-money
Time
Files
IPO
4.50 SEK
88.59M SEK
04 Sep - 23 Sep 2015
IPO in Hamlet Pharma AB
Type
Price
Pre-money
Time
Files
Directed issue
10.35 SEK
01 Feb 2019
Share issue in Hamlet Pharma AB
Type
Ticker
ISIN
Market
SHARE
HAMLET B
SE0015661152
Spotlight Stock Market
Sweden (SE)
Details of share in Hamlet Pharma AB with ticker HAMLET B
Status
Active
Amount of instruments
100 874 697
Currency
SEK
Type
Price
Pre-money
Time
Files
Rights issue
6.50 SEK
655.69M SEK
06 Jul - 20 Jul 2021
Share issue in Hamlet Pharma AB
Type
Ticker
ISIN
Market
OPTION
HAMLET TO1
SE0007192034
Spotlight Stock Market
Sweden (SE)
Details of option in Hamlet Pharma AB with ticker HAMLET TO1
Status
Archived
Amount of instruments
2 750 000
Currency
SEK
Trading period
23 Oct 2015 - 20 May 2016
Terms
One (1) warrant of series TO1 entitles the holder to subscribe for one (1) new share in the Company for SEK 4.50 during the period May 10, 2016 - May 24, 2016.
Update (10.05.2016): Subscription period for TO1 begins today.
Update (16.05.2016): The last day for trading warrants TO1 is 20 May 2016.
Type
Price
Pre-money
Time
Files
Exercise
4.50 SEK
113.34M SEK
10 May - 24 May 2016
Option exercise terms for HAMLET TO1
Type
Ticker
ISIN
Market
OPTION
HAMLET TO2
SE0007192042
Spotlight Stock Market
Sweden (SE)
Details of option in Hamlet Pharma AB with ticker HAMLET TO2
Status
Archived
Amount of instruments
2 750 000
Currency
SEK
Trading period
23 Oct 2015 - 21 Oct 2016
Terms
One (1) warrant of series TO2 entitles the holder to subscribe for one (1) new share in the Company for SEK 4.50 during the period October 11, 2016 - October 25, 2016.
Update (11.10.2016): Subscription period for TO2 begins today.
Update (18.11.2016): The last day for trading warrants TO2 is October 21, 2016.
Type
Price
Pre-money
Time
Files
Exercise
4.50 SEK
125.55M SEK
11 Oct - 25 Oct 2016
Option exercise terms for HAMLET TO2
Type
Ticker
ISIN
Market
OPTION
HAMLET TO3
SE0016276638
Spotlight Stock Market
Sweden (SE)
Details of option in Hamlet Pharma AB with ticker HAMLET TO3
Status
Active
Amount of instruments
3 879 796
Currency
SEK
Trading period
10 Sep 2021 - 27 May 2022
Terms
One (1) warrant of series TO3 entitles the holder to subscribe for one (1) new B share for the price which corresponds to 75 percent of the volume weighted average trading price during the ten (10) trading days preceding May 17, 2022, however, not more than SEK 10.0 per share.
Update (03.09.2021): First trading day for warrants TO3 is September 10, 2021.
Update (06.09.2021): Information regarding Hamlet Pharma warrants.
Type
Price
Pre-money
Time
Files
Exercise
17 May - 31 May 2022
Option exercise terms for HAMLET TO3
Type
Ticker
ISIN
Market
OPTION
HAMLET TO4
SE0016276646
Spotlight Stock Market
Sweden (SE)
Details of option in Hamlet Pharma AB with ticker HAMLET TO4
Status
Active
Amount of instruments
3 879 796
Currency
SEK
Trading period
10 Sep 2021 - 29 May 2023
Terms
One (1) warrant of series TO4 entitles the holder to subscribe for one (1) new A share for the price which corresponds to 75 percent of the volume weighted average trading price during the ten (10) trading days preceding May 17, 2022, however, not more than SEK 13.0 per share.
Update (03.09.2021): First trading day for warrants TO4 is September 10, 2021.
Update (06.09.2021): Information regarding Hamlet Pharma warrants.
Type
Price
Pre-money
Time
Files
Exercise
17 May - 31 May 2023
Option exercise terms for HAMLET TO4
People
Mats Persson
CEO
Catharina Svanborg
Chairman of the board
Bengt Westermark
Board member
Bill Hansson
Board member
Christer Köhler
Board member
Helena Lomberg
Board member
Rolf Carlsson
Board member
Company Details
Sector
HEALTH CARE

Address
Klinikgatan 32
Zip code
222 42
City/district
Lund
Country
Sweden (SE)
Registration number
556568-8958
LEI code
549300HJV2LJY4CDBR64
First trade date
23 Oct 2015
Registration date
29 Mar 1999
Short name
Hamlet

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More